June 15th in Cleveland, Ohio
BioOhio, in partnership with R&Q, is once again teaming up with industry experts to bring you a program focused on regulatory issues pertinent to Ohio’s medical products industry.
This year’s event brings some of the medical device industry’s leading experts direct to you – including FDA (invited), Notified Body, and technical committee representatives. We’ll discuss changing regulations and present actionable recommendations for next steps, along with examining other critical industry trends.
The event will facilitate great industry and professional networking in addition to the valuable content.
The Regulatory Forum is consistently one of our most popular and well attended events.
This event is made possible by generous sponsorship of companies and organizations that value the power of partnerships and networking. Click here to learn more about sponsoring this event.
8:00 – 8:30: Breakfast and Registration
8:30: Welcome and R&Q Introduction
8:35: ISO 13485:2016
Presented by R&Q Director of Minnesota Operations / Principal Consultant – and ISO Technical Committee 210 (TC210) and Working Group 1 (WG1) member – Mark Swanson, this session outlines how organizations should establish a risk-based approach as outlined in the requirements of ISO 13485:2016, and the changes associated with implementation of the new edition of ISO 13485. In this session, we will establish a basic understanding of the application of the risk-based approach in your QMS process, the evidence that will show this implementation to auditors, and how these are implemented in your update to your QMS.
- Mark Swanson, ISO Technical Committee 210 and Working Group 1 member, Director of Minnesota Operations, Regulatory and Quality Solutions (R&Q)
10:00: MDSAP (Medical Device Single Audit Program) – FDA invited
MDSAP can potentially offer a variety of important advantages. While currently optional for FDA, it will be mandatory for Health Canada in January of 2019. Times will be busy with limited qualified registrars, ISO 13485:2016 implementation by March 2019, and EU MDR by 2020. You will leave this session understanding MDSAP inside and out and be sufficiently prepared. Having been on the receiving end of two MDSAP audits, Connie Hoy of Cynosure Inc. (recently acquired by Hologic) will describe her successful first-hand experiences and offer step-by-step practical advice on how to adequately prepare for MDSAP and be successful. Her recent real-world case studies provide the perfect examples of what to do and how to accomplish it.
- Connie Hoy, Senior Vice President of Regulatory Affairs and Quality Assurance, Cynosure, Inc.
11:00: Case for Quality
The Case for Quality has transformed into to a movement for quality beyond compliance. This important initiative between the FDA and medical device industry has moved past the metrics and competencies of quality professionals into maturity models and data analytics that will drive the value proposition of medical devices. Come and hear an update from industry professionals and what you can do in preparation for the next steps coming in this important industry collaboration.
- MDIC (Medical Device Innovation Consortium) representative to be announced
12:00 pm: Lunch
1:00: EU MDR (European Union Medical Device Regulation)
- BSI representative to be announced
2:00: MEDDEV (European guidance)
- BSI representative to be announced
3:00pm: Thought leader discussion and Q&A
The event will be followed by a networking reception at Masthead Brewery, conveniently located next-door to the forum venue.
In partnership with
1100 Superior Ave
Cleveland, OH 44114
Registration includes breakfast, lunch and 1 drink ticket at Masthead Brewery.
BioOhio Member (less than 11 employees): $150
BioOhio Member (11+ employees): $200
Student Member: $75
City and State Government: $150